N/A
N=100
Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms
HIV (Human Immunodeficiency Virus) · AIDS (Acquired Immunodeficiency Syndrome)
Bottom Line
View on ClinicalTrials.gov: NCT03182738 ↗Enrolled (actual)
100
Serious AEs
0.0%
Results posted
Dec 2019
Primary outcome: Primary: Symptom Burden Score — 1.08; 1.06; 0.83; 0.71 score on a scale — p=0.02
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- VIP app without HIV-related symptom strategies. (Behavioral); VIP app that delivers HIV-related symptom strategies. (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Columbia University
- Primary completion
- Apr 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Symptom Burden Score |
1.08; 1.06; 0.83; 0.71; 0.80; 0.78 | 0.02 sig |
| SECONDARY Score on Patient-Reported Outcomes Measurement Information System® (PROMIS)-29 |
43.79; 41.43; 45.37; 41.98; 44.35; 41.63 | 0.83 |
Summary
The purpose of this study is to use technology to improve symptom status and ultimately improve patient centered outcomes in people living with HIV/AIDS (PLWHA). The primary purpose of the intervention (VIP-HANA) is to improve symptom status. The investigators hypothesize that VIP-HANA will improve symptom frequency and intensity.
Eligibility Criteria
Inclusion Criteria
- HIV+
- Age 18 or over
- Able to read and respond in English
- Reside within the US
- Willing to participate in an online survey.
Exclusion Criteria
- HIV-negative
- under age 18
- Unwilling to provide key data (i.e., age, information about symptoms) on the online survey.
Data sourced from ClinicalTrials.gov (NCT03182738). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.